Skip to main content
. 2018 Dec 18;10(1):44–49. doi: 10.15171/jlms.2019.07

Table 3. Prevalence of Side Effects After Treatment With CVL and PDL Systems .

Clinical Symptom Observation Groups
CVL
(n = 635)
PDL
(n = 607)
No. % No. %
Crusts 32 5.1 49 8.1
Edema, Hyperemia 32 5.1 49 8.1
Vesicular rashes, Wetting - 33 5.4
Depigmentation, Hyperpigmentation - 66 10.8
Peeling 17 2.6 16 2.7
Telangiectasia 16 2.7
Total 12.8 37.8